Papadavid E, Kapniari E, Pappa V, Nikolaou V, et al. Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sezary syndrome with variable CD30 positivity. Br J Dermatol 2021;185:1035-1044.
PMID: 34137025